388072-39-7

Basic information

• Product Name: (3-bromo-4-fluorophenyl)methanamine
• Synonyms: (3-bromo-4-fluorophenyl)methanamine
• CAS NO: 388072-39-7
• Molecular Formula: C₇H₇BrFN
• Molecular Weight: 204.0395832
• Mol File: 388072-39-7.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (3-bromo-4-fluorophenyl)methanamine(CAS DataBase Reference)
• NIST Chemistry Reference: (3-bromo-4-fluorophenyl)methanamine(388072-39-7)
• EPA Substance Registry System: (3-bromo-4-fluorophenyl)methanamine(388072-39-7)

Safety Data

• Hazardous Substances Data: 388072-39-7(Hazardous Substances Data)

Usage

Description

(3-bromo-4-fluorophenyl)methanamine is an organic compound with the molecular formula C7H7BrFN. It is an amine and belongs to the class of phenylmethanamines. Characterized by a bromine and fluorine atom attached to the phenyl ring, this compound has a variety of potential applications, including as a building block in synthetic chemistry and as a pharmaceutical intermediate for the production of various drugs. Its unique structure and properties make it a valuable compound for research and industrial purposes.

Uses

Used in Synthetic Chemistry:
(3-bromo-4-fluorophenyl)methanamine is used as a building block for the synthesis of various organic compounds. Its unique structure allows for versatile chemical reactions, making it a valuable component in the creation of new molecules with specific properties.
Used in Pharmaceutical Industry:
(3-bromo-4-fluorophenyl)methanamine is used as a pharmaceutical intermediate for the production of various drugs. Its presence in the molecular structure can contribute to the development of new medications with improved efficacy and reduced side effects.
Used in Research and Development:
(3-bromo-4-fluorophenyl)methanamine is used as a research compound to study its properties and potential applications. Its unique structure and reactivity make it an interesting subject for scientific investigation, potentially leading to new discoveries and innovations in various fields.

Upstream product

• 79630-23-2 3-bromo-4-fluorobenzonitrile 

Downstream Products

• 1624256-21-8 8-(3-bromo-4-fluorobenzyl)-1,3-dimethyl-6,7,8,9-tetrahydropyrazino[2,1-f]purine-2,4(1H,3H)-dione 
• 1245711-57-2 N-(3-bromo-4-fluorobenzyl)tetrahydro-2H-thiopyran-4-amine 
• 1245711-96-9 N-(1,1-dioxidetetrahydro-2H-thiopyran-4-yl)-N-[[6-fluoro-[4'-(trifluoromethoxy)biphenyl]-3-yl]methyl]-1-methyl-1H-imidiazole-4-carboxamide 
• 1245711-89-0 N-[[6-fluoro-4'-(trifluoromethoxy)biphenyl-3-yl]methyl]-1-methyl-N-(tetrahydro-2H-thiopyran-4-yl)-1H-imidiazole-4-carboxamide 
• 1245711-59-4 N-(3-Bromo-4-fluorobenzyl)-1-methyl-N-(tetrahydro-2H-thiopyran-4-yl)-1H-imidazole-4-carboxamide 
• 1262237-80-8 N-(3-bromo-4-fluorobenzyl)-1-methyl-1H-imidazole-4-carboxamide 
• 1262237-81-9 N-(3-bromo-4-fluorobenzyl)-1-methyl-N-propyl-1H-imidazole-4-carboxamide 
• 1208147-68-5 C₂₅H₁₆BrCl₂FN₄O 
• 1174731-57-7 N-(3-bromo-4-fluorobenzyl)formamide 
• 1181078-57-8 N-[(3-bromo-4-fluorophenyl)methyl]-N'-{[1,6-diethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]methyl}-1,1-cyclopropanedicarboxamide 
• 1181078-28-3 N-[(3-bromo-4-fluorophenyl)methyl]-N'-{[1,6-diethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]methyl}propanediamide 
• 1181078-36-3 N-[(3-bromo-4-fluorophenyl)methyl]-N'-{[1,6-diethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]methyl}butanediamide 
• 1178903-83-7 N-[(3-bromo-4-fluorophenyl)methyl]-N'-{[1,6-diethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]methyl}-2,6-pyridinedicarboxamide 
• 1177559-54-4 N-[(3-bromo-4-fluorophenyl)methyl]-N'-{[1,6-diethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]methyl}-1,3-benzenedicarboxamide 

Relevant articles and documents

SULFONYL-SUBSTITUTED BENZOHETEROCYCLIC DERIVATIVE, PREPARATION METHOD AND MEDICAL USE THEREOF

The present invention relates to a sulfonyl-substituted benzoheterocyclic derivative, a preparation method and medical use thereof. Particularly, disclosed is a compound of formula (I) or a pharmaceutically acceptable salt, stereoisomer, solvate, or prodrug thereof, and a preparation method and application thereof. The definition of each group in the formula can be found in the specification and the claims.